- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01295671
Beverages and Societal Health (BASH III)
February 27, 2018 updated by: David S. Ludwig, MD, PhD, Boston Children's Hospital
Sugar Sweetened Beverages And Cardiovascular Disease Risk
The overall aim of the study is to compare the effects of three types of beverages - sugar-sweetened (SSB), artificially sweetened (ASB), and unsweetened (USB) - on cardiovascular disease (CVD) risk factors and body weight among young adults.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Consumption of sugar sweetened beverages (SSB) has been linked to obesity and, independent of body weight, risk for diabetes and cardiovascular disease.
With rising public health awareness of these potential adverse effects, consumption of artificially sweetened beverages (ASB) has increased dramatically.
These low-calorie products are marketed as "diet," with the implication that they promote weight loss and improved health.
However, there are no long-term experimental studies of ASB and body weight or any other health outcome.
Several recent prospective observational studies have linked intake of ASB to increased risk of the metabolic syndrome, type 2 diabetes, and obesity.
In the proposed clinical trial, 270 young adults who habitually consume SSB will be randomly assigned to one of three groups: 1) to continue consuming habitual levels of SSB; 2) to substitute ASB for SSB; or 3) to substitute unsweetened beverages for SSB.
Each group will receive home delivery of the targeted beverage for 1 year, using methods that build upon previous successful work.
Careful attention will be given to assuring treatment fidelity, equivalence of treatment intensity, and avoidance of experimental confounders.
The primary study endpoint will be the ratio of serum triglyceride to HDL-cholesterol concentrations.
Secondary endpoints will include changes in other cardiovascular disease risk factors, body weight, dietary quality, and taste preferences.
Study Type
Interventional
Enrollment (Actual)
203
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Children's Hospital Boston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 18 to 40 years
- Consumption of at least 12 fluid ounces of sugar-sweetened beverage per day
- Willingness to consume types of beverages consistent with group assignment
- Body mass index (BMI) ranging from 18.5 - 40 kg/m2, and body weight ≤275 pounds
- Access to a working telephone or cell phone
Exclusion Criteria:
- Intention to move away from the greater Boston area during the projected period of study enrollment (i.e., 1 year post-randomization)
- Plans to be away from home for 5 weeks or longer during the study period (e.g., moving away from the greater Boston area during the summer)
- Physician diagnosis of a major medical illness, eating disorder, or phenylketonuria (PKU)
- Chronic use of any medication that may affect one or more study endpoints
- Impaired fasting glucose (IFG, fasting blood glucose ≥110 mg/dL)
- Current moderate or heavy smoker (>10 cigarettes per day)
- Another member of the family (i.e., first degree relative) or household participating in the study If female,
- Pregnant in the past 12 months or planning to become pregnant during the study period
- Lactating in the preceding 3 months
- Change in birth control medication in previous 3 months or plans to change during the study period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Sugar-Sweetened Beverages
Provision of beverages: Sugar-sweetened beverages
|
Home delivery of specified beverage type
|
|
Experimental: Artificially-sweetened Beverages
Provision of beverages: Artificially-sweetened beverages
|
Home delivery of specified beverage type
|
|
Experimental: Unsweetened Beverages
Provision of beverages: Unsweetened beverages
|
Home delivery of specified beverage type
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Ratio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)
Time Frame: 12 Month
|
12 Month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
LDL-C
Time Frame: 12 Month
|
LDL-C
|
12 Month
|
|
hsCRP
Time Frame: 12 Month
|
hsCRP
|
12 Month
|
|
Fibrinogen
Time Frame: 12 Month
|
Fibrinogen
|
12 Month
|
|
Uric Acid
Time Frame: 12 Month
|
Uric Acid
|
12 Month
|
|
ALT
Time Frame: 12 Month
|
ALT
|
12 Month
|
|
Systolic Blood Pressure
Time Frame: 12 Month
|
Systolic Blood Pressure
|
12 Month
|
|
Diastolic Blood Pressure
Time Frame: 12 Month
|
Diastolic Blood Pressure
|
12 Month
|
|
Body Weight
Time Frame: 12 Month
|
Body Weight
|
12 Month
|
|
Diet Quality: Sugar-Sweetened Beverage Consumption
Time Frame: 12 Month
|
Diet Quality: Sugar-Sweetened Beverage Consumption - servings per day
|
12 Month
|
|
Preference for Sweet Taste
Time Frame: 12 Month
|
We evaluated preference for sweet taste using ten solutions ranging in sucrose concentration (%m/v) from 0% (sample 1) to 18% (sample 10).
After tasting each solution, participant reported the sample number corresponding to his or her overall favorite.
|
12 Month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ebbeling CB, Feldman HA, Osganian SK, Chomitz VR, Ellenbogen SJ, Ludwig DS. Effects of decreasing sugar-sweetened beverage consumption on body weight in adolescents: a randomized, controlled pilot study. Pediatrics. 2006 Mar;117(3):673-80. doi: 10.1542/peds.2005-0983.
- Ebbeling CB, Feldman HA, Chomitz VR, Antonelli TA, Gortmaker SL, Osganian SK, Ludwig DS. A randomized trial of sugar-sweetened beverages and adolescent body weight. N Engl J Med. 2012 Oct 11;367(15):1407-16. doi: 10.1056/NEJMoa1203388. Epub 2012 Sep 21.
- Ebbeling CB, Feldman HA, Steltz SK, Quinn NL, Robinson LM, Ludwig DS. Effects of Sugar-Sweetened, Artificially Sweetened, and Unsweetened Beverages on Cardiometabolic Risk Factors, Body Composition, and Sweet Taste Preference: A Randomized Controlled Trial. J Am Heart Assoc. 2020 Aug 4;9(15):e015668. doi: 10.1161/JAHA.119.015668. Epub 2020 Jul 22.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Actual)
November 1, 2015
Study Completion (Actual)
November 1, 2015
Study Registration Dates
First Submitted
February 11, 2011
First Submitted That Met QC Criteria
February 11, 2011
First Posted (Estimate)
February 14, 2011
Study Record Updates
Last Update Posted (Actual)
March 27, 2018
Last Update Submitted That Met QC Criteria
February 27, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-06-0242
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease, Obesity
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of California, DavisCompletedCardiovascular Disease | Childhood ObesityUnited States
-
Nemours Children's ClinicCompletedObesity | Cardiovascular Disease
-
University of CincinnatiWithdrawnCardiovascular Disease | Morbid Obesity | Fatty Acid LevelsUnited States
-
LHL HelseNorwegian University of Life Sciences; NIBIO - Norwegian Institute of Bioeconomy... and other collaboratorsCompletedObesity | Cardiovascular DiseaseNorway
-
Pennington Biomedical Research CenterQuest Nutrition LLCWithdrawnObesity | Cardiovascular DiseaseUnited States
-
University of BaselCompletedHypertension | Cardiovascular Disease | Childhood Obesity | Endothelial DysfunctionSwitzerland
-
Penn State UniversityUnited States Department of Agriculture (USDA)CompletedObesity | Cardiovascular DiseaseUnited States
-
Tufts UniversityBoston Nutrition Obesity Research Center (administered by Boston Medical...Completed
-
Loyola UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsWithdrawnObesity | Cardiovascular DiseaseSouth Africa, Jamaica, Ghana, United States, Seychelles
Clinical Trials on Provision of beverages
-
Mexican National Institute of Public HealthCompleted
-
University of PennsylvaniaNational Institute on Aging (NIA)Completed
-
Technical University of MunichBavarian State Ministry of Health and Care; German Alzheimer SocietyCompleted
-
London School of Hygiene and Tropical MedicineEmory University; University of California, Davis; Bill and Melinda Gates Foundation and other collaboratorsCompletedNutritional Status | Diarrhoea | Soil-transmitted Helminth InfectionIndia
-
University of NottinghamCompleted
-
University of California, San DiegoCompleted
-
Federal University of Minas GeraisCompleted
-
Marcos Vera HernandezEvidence Action; MaiMwanaCompleted
-
Cornell UniversityUniversity of Maryland; The Nelson Mandela African Institution of Science and...Completed
-
The Bionics Institute of AustraliaRecruitingHearing ImpairmentAustralia